checkAd
    Startseite > Aktien > Marinus Pharmaceuticals > Nachrichten
    Marinus Pharmaceuticals Aktie
    1,4200
     
    USD
    -2,74 %
    -0,0400 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,4100
     
    USD
    31.900 STK
    Geldkurs 31.05.24
    1,4200
     
    USD
    11.500 STK
    Briefkurs 31.05.24
    ISIN: US56854Q2003 · WKN: A2QEUC · SYM: MRNS · USA

    Neueste Nachrichten

    Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program
    17.05.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
    08.05.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference
    02.05.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024
    01.05.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
    15.04.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    05.04.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
    27.03.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    05.03.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
    21.02.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
    20.02.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    16.02.24 · Business Wire (engl.) · Marinus Pharmaceuticals
    Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    04.01.24 · Business Wire (engl.) · Marinus Pharmaceuticals